These substances, including 3mmc, Alpha-PiHP, MDPHP, and 2mmc, represent a emerging category of novel psychoactive substances . Often sold as substitutes, they mimic the effects of established depressants but lack extensive clinical data. Individuals should be aware that the consequences of these substances are insufficiently understood and can be